Search Results for “cancer” – Page 138 – media

A Kale a Week Keeps Hepatitis Away

A lot concerning our health comes down to what we eat. There are many nutritious foods available which should specifically be consumed if you suffer from a health condition. Hepatitis is no different. There is one food source which can prevent liver diseases to a greater extent. In recent times, kale has gained a reputation for being a considered super food, especially for people with any type of liver disease including hepatitis.
- Source: LiverSupport
- 490
- July 21, 2018
health tips hepatitis Researches
Urine Leakage – Causes and Management

Urinary leakage or urinary incontinence happens when someone passes urine unintentionally, ranging from frequent small drops to a large flood of urine. The situation is both disturbing and embarrassing and creates various hygiene issue.
- Source: Healyhline
- 476
- July 20, 2018
Researches urine incontinence
HCV RNA PCR Test; Qualitative and Quantitative Analysis

The HCV RNA PCR test is a blood test that is advised by doctors in suspected patients to diagnose Hepatitis C infection. It calculates the hepatitis C viral load in the bloodstream. This article gives an insight into how the test functions and what the results signify.
- Source: MedicalNewsToday
- 1,376
- July 20, 2018
blood test hepatitis C Researches
Create Personalized Bone Grafts with SATE

A team of scientists from the New York Stem Cell Foundation (NYSCF) Research Institute has developed a new bone engineering technique named Segmental Additive Tissue Engineering (SATE). With this technique, segments of bone engineered from stem cells fuse together to form large-scale, personalized grafts.
- Source: The Verdict
- 610
- July 20, 2018
Bone Graft Researches
K Health Announces Launch of Free Primary Care App and $12.5 New Funding

K, a new free primary care app was launched by the individualized health information company, K Health. The app’s AI scours through the history of diagnoses and treatments to provide the user with the most likely treatment of their condition and can simultaneously connect them to a network of primary health care providers.
- Source: MobiHealthNews
- 760
- July 19, 2018
Company Insight digital health mHealth
Hidden Blood in Stool Could Predict Fatal Health Conditions

If a drop of blood is seen in stool, people tend to panic. The causative factors could include digestive, respiratory, circulatory, hematological or even neuropsychological diseases.
- Source: MedicalXpress
- 685
- July 18, 2018
bowel cancer Researches
TREAT-B – Blood Test to Detect Hepatitis B Well in Advance

Viral hepatitis is a major global health issue since it is the seventh leading cause of death worldwide. Around half of hepatitis-related deaths reported are due to the hepatitis B virus infection, which is transmitted through blood and body fluids.
- Source: MedIndia
- 401
- July 18, 2018
blood test hepatitis B Researches
Novartis Shuts Down Its Antimicrobial Research

Despite the looming crises, Novartis will be shutting down antimicrobial research at its Novartis Institutes for Biomedical Research campus in Emeryville, California. There will be a loss of 140 jobs and the current projects will be put up for sale. This company was working on phase 2 clinical trial of LYS228 against complicated urinary tract infections and complicated intra-abdominal infections. The work on anti-dengue drugs and anti-malaria drugs (KAF156 and KAE609) were already in pipeline.
- Source: Fierce Biotech
- 728
- July 16, 2018
AMR antibiotic resistance Company Insight
Robotic Surgery – Effective as Traditional Open Surgery Via RAZOR Trial

The US-based RAZOR (Randomised Open versus Robotic Cystectomy) trial revealed that robotic surgery is equally effective as traditional open surgery in order to treat bladder cancer. The study was funded by the National Cancer Institute and the discovery was published in the Lancet.
- Source: The Verge
- 1,921
- July 16, 2018
medical device Researches robotic surgery
Dual Therapy of Ibrutinib Plus Venetoclax Improves Results in MCL

Ibrutinib plus venetoclax (ABT-199) improves outcomes over standard therapy in patients with mantle-cell lymphoma (MCL) and a poor prognosis reports a new research in the New England Journal of Medicine.
- Source: MDLinx
- 740
- July 14, 2018
cancer mantle cell lymphoma Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.